Medicine & Life Sciences
Belgium
100%
HIV
85%
HIV-1
61%
Dendritic Cells
52%
Acquired Immunodeficiency Syndrome
28%
T-Lymphocytes
26%
Highly Active Antiretroviral Therapy
23%
Vaccination
22%
Coronavirus
21%
Viruses
18%
CD4 Lymphocyte Count
18%
Therapeutics
18%
Superinfection
18%
Clinical Trials, Phase I
17%
Vaccines
16%
Phase II Clinical Trials
16%
Fever
15%
Anti-Bacterial Agents
15%
Immunologic Monitoring
14%
Prescriptions
14%
Infections
14%
Continuity of Patient Care
13%
Drug Resistance
12%
Respiratory System
12%
Bone Marrow
12%
Delivery of Health Care
12%
Multiple Myeloma
12%
Human Immunodeficiency Virus-1 rev protein
11%
Respiratory Tract Infections
11%
Epitopes
11%
Public Health
11%
C-Reactive Protein
10%
Immunotherapy
10%
Viral Load
10%
Mutation
10%
Intercellular Adhesion Molecule-1
10%
Type 1 Spherocytosis
10%
Disease Outbreaks
10%
Survivors
10%
Messenger RNA
10%
HIV Infections
9%
Human immunodeficiency virus 1 nef protein
9%
Silver Staining
9%
Acute Myeloid Leukemia
9%
Skin Cream
9%
Data Analysis
9%
dolutegravir
9%
Interleukin-6
8%
Lamivudine
8%
Atazanavir Sulfate
8%
Social Sciences
Belgium
46%
AIDS
35%
migrant
29%
Healthcare
12%
public health
10%
anxiety
6%
vaccination
6%
surveillance
6%
contagious disease
5%
